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ABSTRACT 
Background: Unicuspid aortic valve (UAV) is a rare disorder, often difficult to distinguish from 
bicuspid aortic valve (BAV).  BAV and UAV share valve pathology such as the presence of a 
raphe, leaflet fusion, aortic stenosis, aortic regurgitation, and/or ascending aortic dilatation, but a 
comprehensive echocardiographic comparison of patients with UAV and BAV has not been 
previously performed. 
Methods: We investigated UAV and BAV patients at an early stage of disease included in 
GenTAC, a national registry of genetically-related aortic aneurysms and associated cardiac 
conditions.  Clinical and echocardiographic data from the GenTAC registry were compared 
between 17 patients with UAV and 17 matched-controls with BAV.  
Results: Baseline characteristics including demographics, clinical findings including family 
history of BAV and aortic aneurysm/coarctation, and echocardiographic variables were similar 
between BAV and UAV patients; aortic stenosis was more common and more severe in patients 
with UAV.  This was evidenced by higher mean and peak gradient, smaller aortic valve area and 
more advanced valvular degeneration (all p<0.05).  There were no significant differences in 
aortic dimensions, with a similar pattern of enlargement of the ascending aorta.  
Conclusion: The similar baseline characteristics with more accelerated aortic valve degeneration 
and stenosis, suggests that UAV represents an extreme in the spectrum of BAV syndromes.  
Therefore, it is reasonable to consider application of recommendations for management of 
patients with BAV to those with the rarer UAV.   
 
 
Key Words: Bicuspid aortic valve; Unicuspid aortic valve; Congenital heart disease 
Page 2 of 26
Congenital Heart Disease
Congenital Heart Disease
This article is protected by copyright. All rights reserved.
A
cc
ep
te
d 
A
rt
ic
le
 
 
 
3 
Introduction  
Unicuspid aortic valve (UAV) is a rare congenital disorder with a prevalence that ranges 
from 0.02% in the echocardiographic referral population to 4-6% in patients undergoing valve 
replacement for aortic stenosis.
1,2, 3
  Bicuspid aortic valve (BAV) disease, on the other hand, is 
the most common congenital cardiac malformation with a prevalence of about 1-2% in the 
general population.
4
  UAV and BAV have similar clinical presentations (aortic stenosis or 
regurgitation) but the associated pathologies of UAV seem to develop earlier and progress at a 
faster rate than BAV.
1
  Indeed, most case series of patients with UAV describe young individuals 
with advanced valvular disease presenting for valve replacement.  UAV is characterized as 
having either an eccentric, unicommissural orifice or a pinhole-shaped acommissural opening 
presenting with severe stenosis at birth.
1,5,6,7
  Unicommissural valves have a larger effective 
orifice area than acommissural valves; however, both have a smaller, rounded free edge 
compared to a trileaflet aortic valve (TAV).
6,8,9,10,11
  This severely narrowed opening and 
predilection for accelerated calcification of the aortic valve results in more frequent and earlier 
onset of aortic stenosis than found in individuals with BAV or TAV.
6,12,13  
The more severe 
pathology that correlates with the lower number of cusps suggests that there may be a phenotypic 
continuum of similar disease spanning from BAV to UAV.
14
  Despite this hypothesized 
continuum, to our knowledge an echocardiographic and clinical analysis of patients with UAV 
and BAV has never been performed.  Whether they represent a spectrum of the same disease or 
they are, indeed, different conditions have yet to be determined.  Furthermore, the prevalence of 
aortopathies in the UAV has not yet been thoroughly examined.   
We undertook a comprehensive phenotypic and clinical comparison of patients with 
UAV and BAV enrolled in the national registry of patients with Genetically-related Thoracic 
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Aortic Aneurisms and related cardiac conditions (GenTAC).  GenTAC represents a unique 
opportunity to compare these two populations, as patients were enrolled at different stages of the 
disease, including those early in the progression.  Our hypothesis is that patients with UAV and 
BAV share valvular and non-valvular features suggesting a common developmental defect in 
cusp separation or outflow tract septation and that UAV may represent a phenotypic extreme of 
the BAV spectrum. 
 
Methods 
Patients in GenTAC were enrolled at 8 nationally recognized centers for management of 
aortic diseases related to genetic conditions (Johns Hopkins, Baltimore; Weill Cornell Medicine, 
New York; University of Pennsylvania, Philadelphia; Baylor Medical Center, Houston; 
University of Texas, Houston; Oregon Health & Science University, Portland; Queen’s Hospital, 
Honolulu; National Institutes of Aging, Baltimore).  Patients were enrolled on the basis of a 
diagnosis of a condition with genetically-associated aortopathy (BAV was the most frequent 
enrollment diagnosis).  The rationale and design of GenTAC have been previously described.
15,16
 
The GenTAC Registry is co-sponsored by the National Heart Lung and Blood Institute and the 
National Institute of Arthritis and Musculoskeletal and Skin Diseases.  Patients gave written 
informed consent, and enrollment centers transmitted comprehensive case report forms to the 
data coordinating center (RTI, Rockville MD).  
All patients in the GenTAC Registry that were diagnosed with a UAV by 
echocardiogram were included.  A matched-control group consisting of GenTAC patients with 
BAV was created on a 1:1 ratio.  To best identify a control group, matching was done on the 
basis of three clinical variables known to have an impact in valvular hemodynamics and aortic 
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enlargement with BAV cohorts (age, gender and body surface area (BSA)).  For any given UAV 
patient, a control BAV individual was identified with an exact age and gender match, and with 
the closest BSA. Given the small number of cases with UAV (and therefore of the control 
cohort), there was no attempt to compare genetic similarities among groups. 
Echocardiograms in GenTAC were obtained at the enrolling centers and submitted for 
analysis to a centralized imaging Core Lab (iCORE, MedStar Health Research Institute, 
Washington, DC).  All echocardiograms were analyzed according to a protocol that was agreed 
upon by the imaging experts from the iCORE and the enrolling centers.  The image analysis 
protocol has been previously described in detail.
17
 In brief, all echocardiograms were analyzed 
by a single echocardiographer, blinded to the enrollment diagnosis and any clinical information.  
Aortic measurements were performed at predetermined aortic locations at end systole using the 
inner edge to inner edge technique and are reported as absolute dimensions.  BAV was diagnosed 
as a valve with two commissures and an oval, “football-like” opening (Figure 1, left panel).  
UAV was defined as a valve with one or zero commissures and a rounded, “soccer ball-like” 
opening (Figure 1, center panel).  Aortic valve regurgitation and stenosis were evaluated 
according to current American Society of Echocardiography guidelines.
18,19
 AVA (aortic valve 
area) was calculated by using the continuity equation with peak left ventricular outflow tract and 
aortic valve velocities.  AVA was indexed to body surface area to classify aortic stenosis as mild 
(>0.85 cm
2
/m
2
), moderate (0.60-0.85 cm
2
/m
2
), or severe (<0.60 cm
2
/m
2
).  An aortic valve 
degeneration score for both UAV and BAV was calculated according to criteria described by 
Michelena et al.
20
  Valvular degeneration was evaluated by scoring three separate components 
including leaflet thickening, mobility and calcification as 0 (normal), 1 (mildly abnormal), 2 
(moderately abnormal), or 3 (severely abnormal).  The three individual scores were added 
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together to generate a composite degeneration score with a potential maximum score of 9.   A 
comprehensive echocardiographic and clinical comparison of the two phenotypic groups was 
subsequently performed.  
Statistical analyses were performed at the GenTAC data-coordinating center (RTI) using 
SAS version 9.3 with a two-tailed p < 0.05 considered statistically significant.  Classification of 
aortic valve stenosis and aortic valve regurgitation were placed into one of three groups: none, 
mild, or moderate and severe.  Data are presented as mean ± standard deviation for continuous 
variables and as percentages for categorical variables.  All continuous variables were compared 
using Student’s t-tests while discrete variables were compared by Chi-square analysis or Fisher’s 
exact test.      
 
Results 
UAV was diagnosed in 17 GenTAC participants by echocardiography.  BAV was 
diagnosed in over 600 patients, from which 17 were identified as matched controls based on 
gender, age and BSA for each of the UAV cases.  The demographic and clinical characteristics 
of the subjects are described in Table 1.  By study design, UAV and BAV groups were matched 
in mean age (15.4 years, range 2 months – 47 years) and gender (71% male).   Five patients in 
each group had either evidence of aortic coarctation by echocardiography or a history of 
coarctation repair; only one BAV patient had suffered an aortic dissection.   
Interestingly, there were 3 patients in each group that had a family history of one or more 
of the following: BAV, aortic coarctation, or aortic aneurysm.  Specifically, similar proportions 
of UAV and BAV patients had family histories of BAV (3 vs. 1), aortic coarctation (1 vs. 0) and 
aortic aneurysm (1 vs. 2).  
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Echocardiographic analysis of UAV and BAV groups is shown in Table 2.  There was no 
difference in aortic dimensions at any pre-specified level of the aorta.  In both groups, the 
majority of patients had the classic phenotype of dilated ascending aorta described for BAV, 
characterized by the ascending aorta being larger than the sino-tubular junction (UAV 93.3% vs. 
BAV 81.3%, p=0.316), which is demonstrated in Figure 1 (right panel).
21
 Interestingly, a finding 
of an ascending aorta being larger than the aortic root (at the sinuses of Valsalva) was seen more 
frequently in UAV than in BAV patients (86.7% vs. 50%, p=0.029).   
On evaluation of valvular hemodynamics, there was no difference between the two 
groups with respect to the incidence and severity of aortic regurgitation.  However, aortic 
stenosis was significantly more common in cases of UAV.  Patients with UAV were more likely 
to have moderate or severe aortic stenosis than those with BAV (58.8% vs. 17.6%, p=0.011).  
Accordingly, UAV patients had significantly greater mean aortic valve gradients than patients 
with BAV (22.4 mmHg vs.10.4 mmHg, p<0.001) and greater peak aortic valve gradients (39.2 
mmHg vs.18.6 mmHg, p<0.001).   In addition to hemodynamic measures, there were significant 
differences between the two groups with respect to aortic valve degeneration as UAV subjects 
had significantly greater mean degeneration scores (2.8) than BAV subjects (1.7, p=0.043).   
Interestingly, the most notable difference between the two groups was seen in leaflet mobility 
characteristics as patients with UAV had mild-moderately reduced mobility (mean score 1.6) 
while BAV patients had only slightly abnormal leaflet mobility (mean score 0.7, p<0.001).  
To further characterize patients with aortic stenosis and their degree of valvular 
degeneration, a subset analysis was performed in subjects found to have any degree of aortic 
stenosis (Table 3).  Included in this analysis were 15 patients with UAV and 5 patients with 
BAV.  Patients with UAV had more significant aortic stenosis than BAV patients (Indexed AVA 
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= 0.67 cm
2
/m
2
 vs. 0.90 cm
2
/m
2
, p= 0.011).   Although UAV patients with stenosis tended to be 
younger and have greater mean and peak aortic valve gradients than BAV patients, these 
differences were not statistically significant.  Of note, patients in both groups had aortic stenosis 
despite having small degeneration scores with minimal calcification and thickening, a reflection 
of the young age and the restricted leaflet motion.  Accordingly, the aortic valves of the UAV 
group had significantly decreased mobility compared to the BAV group (1.7 vs. 0.8, p = 0.005).   
 
Discussion 
Prior reports of UAV have included only data from postmortem or postsurgical 
specimens.
2
 This study is unique in that our population precedes significant aortic valve disease 
progression resulting in either death or surgical intervention to the aortic valve.  We performed a 
comprehensive comparison of UAV and BAV patients that were age, gender, and BSA matched 
within the GenTAC Registry, to understand how similar (or dissimilar) these pathologies are.  To 
our knowledge, this is the first study that combines echocardiographic and clinical evaluation of 
UAV and BAV in living patients not yet planning surgical valve replacement.  Our findings are 
that: 1) demographic and clinical characteristics are similar; 2) family history of BAV and BAV-
associated aortopathy was equally present in those with BAV and UAV; and 3) UAV patients 
have more degeneration of the aortic valve (mostly limited leaflet mobility) and therefore have a 
higher prevalence and severity of aortic stenosis. 
It is interesting that the aortic dimensions, family history, and prior aortic surgeries were 
similar between the two groups.  Furthermore, the majority of patients in both groups exhibited 
the typical pattern of dilated ascending aorta for BAV, postulated to be related to sheer stress on 
the ascending aorta due to turbulent flow through a narrowed aortic valve orifice.
21,22
 
Page 8 of 26
Congenital Heart Disease
Congenital Heart Disease
This article is protected by copyright. All rights reserved.
A
cc
ep
te
d 
A
rt
ic
le
 
 
 
9 
Intriguingly, the ascending aorta was larger than the aortic root more commonly in UAV than 
BAV, perhaps reflective of a more severe phenotypic pattern of the aortopathy or the 
hemodynamic consequences of more severe aortic stenosis.  Patients from both populations had 
similar rates of aortic coarctation necessitating repair along with rates of surgical intervention at 
all pre-specified levels of the aorta.  Similar to the pattern seen in BAV, UAV was also more 
common in males than females.
12,14
 Of note, a family history of BAV or of aortic 
aneurysm/dissection or coarctation was equally common in UAV and BAV individuals, 
suggesting a common, likely genetic, familial predisposition to these two forms of aortic valve 
pathology.  Larger series of BAV patients have described a heritable pattern of BAV and the data 
from the present study suggests there is a common inheritance pattern in UAV patients.
23
 Given 
the lack of leaflet thickening and calcification, the degree of stenosis found in BAV and UAV is 
mostly due to differences in the cusp morphology impeding appropriate valve opening.  The 
combination of these findings suggests that there is a common link in the inheritance patterns of 
patients with UAV and those with BAV. 
To the extent that UAV and BAV share a common underlying predisposition, UAV 
appears to represent a more severe phenotype as patients with UAV tend to have earlier onset 
and faster progression of aortic stenosis, consistent with prior studies evaluating pathologic 
specimens of surgically excised aortic valves.
1,2
  Patients with UAV had smaller indexed aortic 
valve areas along with greater mean and peak aortic valve gradients than the BAV cohort, likely 
due to both the leaflet morphology as well as calcific progression.  When analyzing the subset of 
patients from both groups diagnosed with aortic stenosis, UAV subjects had more severe aortic 
stenosis than BAV patients.  Additionally, they tended to be younger than those with a BAV, 
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although this was not statistically significant, possibly as a result of the relatively small sample 
size. 
The mechanism for this pattern of aggressive aortic stenosis appears to be related mostly 
to leaflet mobility.  Overall, patients with UAV had significant reduction of leaflet mobility 
whereas patients in the BAV cohort had only slightly reduced leaflet mobility, even when 
evaluating the subset of subjects with aortic stenosis.  Both the presence and severity of aortic 
stenosis are most closely linked to reduced leaflet mobility, particularly in patients with UAV.  
One explanation for the low valve degeneration scores may be the young age of our patient 
population.  In a prior study, Michelena et al. noted that BAV patients with valve degeneration 
had a mean age of 52 along with a relatively high prevalence of hypertension (43%), both of 
which result in increased valve thickness and calcification.
20
   Aortic valves from the UAV and 
BAV groups in the present study did not demonstrate marked calcification or thickness given the 
young age of our study group (mean age 15.4 years).  Additionally, much of the literature 
comparing BAV and UAV only includes excised valves from patients whose disease had 
progressed to either death or surgical intervention.
2,24
 These patients were older and represent a 
subset of the UAV and BAV population with advanced aortic valve disease and were far more 
likely to have significant valvular calcification and dystrophic aortic valves.  While calcification 
of trileaflet aortic valves occurs naturally in patients after the age of 40, valves become more 
dystrophic and more stenotic earlier in life in both UAV and BAV.
24,25
    
Current recommendations for the management of patients with BAV are based on 
observations of large cohorts of patients.  UAV, on the other hand, is a very rare condition and 
the observations are anecdotal in nature as most information about UAV has been gained from 
postmortem and post-surgical analysis.  Demonstrating similarities between these two 
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populations may allow adoption of current recommendations for management of BAV to patients 
with UAV with the understanding that aortic stenosis and aortic complications tend to occur 
earlier in those patients with UAV.  Prior reports have demonstrated that patients with a more 
aggressively stenotic UAV manifest with early aortic involvement that is associated with an 
increased incidence of ascending dilatation, dissection and rupture.
1,12,26
  Owing to the earlier 
presentation and increased likelihood of more severe stenosis, UAV typically requires surgical 
treatment at least one to two decades earlier than BAV.
8
  Furthermore, with increasing patient 
age, differentiation between UAV and BAV can be challenging as focal calcification of UAV 
can mimic the appearance of the raphe seen in BAV on echocardiography.
6,11
  If cardiac imaging 
cannot distinguish between UAV and BAV then application of current BAV guidelines to these 
patients is an appropriate course of action with close monitoring for complications of both the 
aortic valve and aorta.  
While our study has novel and interesting findings, some limitations must be 
acknowledged.  The number of patients in the GenTAC registry with UAV was small, albeit 
larger than for any previous study. We were able to take advantage of the large number of 
subjects with BAV in the GenTAC cohort to identify a control group that was matched by the 
most significant demographic characteristics, therefore allowing a meaningful comparison of 
BAV and UAV patients.  Unfortunately, the small number of cases also prevents a proper 
comparison of genetic variants, the ultimate method to prove the proposed linkage between BAV 
and UAV.  Furthermore, the study likely did not capture UAV patients that required procedures 
early in life, particularly individuals with acommissural aortic valves as they tend to have an 
aggressive clinical course.  Moving forward, it would be valuable to investigate the progression 
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of both BAV and UAV over time as the present study lacks long term longitudinal monitoring of 
disease progression and development.  
 Although UAV and BAV have distinctly different morphologies, the findings of this 
study suggest that they represent a continuum of the same disease.  Patients with UAV represent 
a more aggressive phenotype in the spectrum of BAV syndromes, presenting with more severe 
aortic stenosis at a younger age compared to BAV.  Adoption of current recommendations for 
the management and monitoring of BAV to patients with UAV is a reasonable consideration, 
with the understanding that both aortic stenosis and aortic complications occur earlier in patients 
with UAV.    
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FIGURE CAPTIONS 
Figure 1. Examples of bicuspid and unicuspid aortic valves (BAV and UAV, respectively) and 
typical ascending aortic enlargement in these conditions.  BAV was defined as having two 
commissures (arrows) and an oval, “football-like” opening (left panel).  UAV was defined as a 
valve with one (or none) commissure and a rounded, “soccer ball-like” opening (center panel). 
Both examples are shown from a parasternal short axis view.  In both conditions, enlargement of 
the ascending aorta (classically described for BAV) was frequently found, shown in the right 
panel from a suprasternal notch view (dilated ascending aorta marked in full line, normal 
descending in dotted line). 
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Figure 1. Examples of bicuspid and unicuspid aortic valves (BAV and UAV, respectively) and typical 
ascending aortic enlargement in these conditions.  BAV was defined as having two commissures (arrows) 
and an oval, “football-like” opening (left panel).  UAV was defined as a valve with one (or none) commissure 
and a rounded, “soccer ball-like” opening (center panel). Both examples are shown from a parasternal short 
axis view.  In both conditions, enlargement of the ascending aorta (classically described for BAV) was 
frequently found, shown in the right panel from a suprasternal notch view (dilated ascending aorta marked 
in full line, normal descending in dotted line).  
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Table I. Patient Demographics  
 UAV BAV p value 
Age, years 15.4 15.4 -- 
Male (%) 70.6% 70.6% -- 
Body Surface Area, m
2
 1.25 1.22 -- 
Aortic Surgeries (n, %)    
     Ascending  1 (5.9) 2 (11.8) 1.000 
     Arch and Descending 0 (0.0) 1 (5.9) 1.000 
Coarctation Repair 4 (23.5) 3 (17.6) 1.000 
Aortic Dissection (n, %) 0 (0.0) 1 (5.9) 1.000 
Family History of Disease n = 8 n = 11  
     BAV 3 1 0.260 
     Aortic Coarctation 1 0 0.420 
     Marfan Syndrome 0 1 1.000 
     Aortic Aneurysm 1 2 1.000 
     Aortic Dissection 0 0 1.000 
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Table II. Echocardiographic and Hemodynamic Data 
Echo Findings UAV BAV p value 
AV gradient, mm Hg (mean, SD)    
     Mean 22.4 (10.6) 10.4 (7.6) <0.001 
     Peak 39.2 (17.3) 18.6 (15.6)  <0.001 
AV stenosis (n, %)   0.011 
     None 2 (11.7) 11 (68.75)  
     Mild 5 (29.4) 2 (12.5)  
     Moderate or Severe 10 (58.8) 3 (18.75)  
AV regurgitation   0.110 
     None 1 (5.9) 6 (35.3)  
     Trivial or Mild 13 (76.5) 10 (58.8)  
     Moderat  or Severe 3 (17.6) 1 (5.9)  
AV Degeneration Score (mean, SD)
a 2.8 (1.6) 1.7 (1.3) 0.043 
     Mobility
b 1.6 (0.6) 0.7 (0.6) <0.001 
     Thickness
b 0.9 (0.7) 0.8 (0.5) 0.718 
     Calcification
b 0.3 (0.7) 0.2 (0.5) 0.608 
Aortic dimensions, cm (mean, SD)    
     Annulus 2 (0.6) 1.9 (0.5)  0.656 
     Sinus of Valsalva 2.7 (0.8) 2.8 (0.9) 0.900 
     ST Junction 2.3 (0.7) 2.2 (1.8) 0.570 
     Ascending Aorta 3 (1.0) 2.7 (0.8) 0.232 
     Proximal Arch 2 (0.7) 2.1 (0.8) 0.757 
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     Transverse Arch 1.6 (0.6) 1.8 (0.7) 0.487 
     Isthmus 1.2 (0.4) 1.3 (0.4) 0.696 
     Descending Aorta 1.3 (0.3) 1.6 (0.5) 0.140 
a
Aortic Valve Degeneration graded from 0 (none) to 9 (severe) based on the summation of three 
components: leaflet mobility, thickness and calcification 
b
Graded on a scale of 0 (normal), 1 (mildly abnormal), 2 (moderately abnormal), 3 (severely 
abnormal) 
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Table III. Comparison of Subjects with Aortic Stenosis 
Variable UAV (n=15) BAV (n=5) p value 
Age, years (mean, SD) 15.3 (15.3) 22.6 (20.8) 0.406 
AV gradient, mm Hg (mean, SD)     
     Mean 24.3 (9.6) 19.4 (7.6) 0.312 
     Peak 42.6 (15.2) 37.2 (16.5) 0.509 
Indexed AVA, cm
2
/m
2
 (mean, SD) 0.67 (0.12) 0.90 (0.22) 0.011 
AV Degene ation Score (mean, SD)
a 3.1 (1.5) 2.4 (1.7) 0.410 
     Mobility
b 1.7 (0.5) 0.8 (0.8) 0.005 
     Thickness
b 1 (0.7) 1.2 (0.4) 0.537 
     Calcification
b 0.3 (0.7) 0.4 (0.9) 0.868 
a
Aortic Valve Degeneration graded from 0 (none) to 9 (severe) based on the summation of three 
components: leaflet mobility, thickness and calcification 
b
Graded on a scale of 0 (normal), 1 (mildly abnormal), 2 (moderately abnormal), 3 (severely 
abnormal) 
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